Septerna Inc.

About Septerna Inc.

Septerna is a biotechnology company focused on pioneering a new era of G protein-coupled receptor (GPCR) drug discovery. Their mission is to unlock the full potential of GPCR drug targets to develop impactful new medicines for patients across various therapeutic areas, driven by a world-class team of drug hunters, GPCR experts, and company builders.

Products & Services

Native Complex Platform™:An industrial-scale platform designed to unlock previously difficult-to-drug GPCRs, leading to the discovery, optimization, and development of oral small molecule drug candidates.

Pipeline of Oral Small Molecule GPCR Programs:A deep pipeline of drug candidates in development and discovery, initially focused on treating patients in endocrinology, immunology and inflammation, and metabolic diseases.

SEP-631:An oral small molecule MRGPRX2 negative allosteric modulator for the treatment of mast cell-driven diseases, currently in Phase 1 clinical trials.

Specialties

G protein-coupled receptor (GPCR) drug discovery Oral small molecule drug development Endocrinology Immunology and Inflammation Metabolic Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 331200000 MR: - FA: $331.2 million FAN: 331200000	D: 2024-10-30 FD: 2024-10-30	4 investors
2	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 288000000 MR: - FA: $288.0 million FAN: 288000000	D: 2024-10-24 FD: 2024-10-24	4 investors
3	RT: Series B T: - FT: Series B	A: 150000000 MR: - FA: $150 million FAN: 150000000	D: 2023-07-11 FD: 2023-07-11	16 investors

Initial Public Offering (IPO) Latest

2024-10-30

$331.2M

4 investors (Pro only)

Initial Public Offering (IPO) 2024-10-24

$288.0M

Series B 2023-07-11

$150.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jeffrey Finer

Chief Executive Officer and Co-Founder

G

Gil Labrucherie

Chief Financial Officer

L

Liz Bhatt

President and Chief Operating Officer

S

Samira Shaikhly

Chief People Officer

U

Uwe Klein, PhD

Senior Vice President, Biological Sciences

J

Jae Kim, MD

Chief Medical Officer

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Septerna Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised